Glaucoma News

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Michelle Senchyna, PhD, of Aerie Pharmaceuticals, provides an update on the company’s ongoing projects.

CHICAGO — In this Healio Video Perspective from the AAO meeting, I. Paul Singh, MD, shares data about the Glaukos iStent infinite, designed to reduce IOP.

In this exclusive surgical video for Healio/OSN, I. Paul Singh, MD, uses the iStent inject and the iAccess microgoniotomy device to demonstrate a technique for combining stenting and goniotomy for patients with glaucoma.

CHICAGO — Once-daily sepetaprost was noninferior to twice-daily timolol in reducing IOP in patients with primary open-angle glaucoma or ocular hypertension, according to a study presented at the American Academy of Ophthalmology meeting.

MILAN — In a satellite symposium sponsored by Glaukos at the ESCRS meeting, Gokulan Ratnarajan, MD, presented the results of a study on cataract surgery combined with the Glaukos iStent and endocyclophotocoagulation.

TC-002, a latanoprost ophthalmic solution, met all primary and secondary endpoints in the phase 3 CLEAR pivotal trial, according to a press release from TearClear.

As a specialty, glaucoma has had no shortage of innovation in recent years.

In the United States, we are now required by the ICD-10 system of coding to provide a seven-digit code when billing for glaucoma.

The reason the NICE guidelines advise trabeculectomy at presentation with advanced disease is simply that the greatest risk factor for severe visual loss in glaucoma is advanced disease at presentation.

Early detection and appropriate management allow most patients to stave off progression of glaucoma beyond the mild to moderate stages and preserve vision.